Literature DB >> 8166686

Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.

B J Blanchard1, R devi Raghunandan, H M Roder, V M Ingram.   

Abstract

Abnormal hyperphosphorylation of the cytoskeletal protein TAU is seen in the characteristic paired helical filaments [neurofibrillary tangles] of Alzheimer's disease [AD]. A recently described protein kinase, PK40erk, (1) a member of the ERK family of kinases, can produce in vitro many of the properties of Alzheimer-like hyperphosphorylated TAU. cAMP-dependent protein kinase A [PKA] phosphorylates TAU to a lesser extent; however, the product is not like the hyperphosphorylated TAU of AD in several important respects. We now report that in vitro PK40erk, a candidate for the enzyme responsible for TAU hyperphosphorylation in AD, will further phosphorylate TAU that was previously saturated by protein kinase A, provided that the concentrations of free uncomplexed ATP are low. Interestingly, the actions of different kinases on TAU are not independent, but may depend on the order in which they work on TAU; i.e., prior phosphorylation by PKA partially inhibits the action of PK40erk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166686     DOI: 10.1006/bbrc.1994.1432

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

2.  Phosphorylation of tau alters its association with the plasma membrane.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  2000-08       Impact factor: 5.046

3.  The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes.

Authors:  T B Shea; C M Cressman
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

4.  Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding.

Authors:  Chad J Leugers; Gloria Lee
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

Review 5.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

7.  Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.

Authors:  M L Bush; J S Miyashiro; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.

Authors:  Lisa Kirouac; Alexander J Rajic; David H Cribbs; Jaya Padmanabhan
Journal:  eNeuro       Date:  2017-03-27

Review 9.  Sex differences in chronic stress responses and Alzheimer's disease.

Authors:  Yan Yan; Sky Dominguez; Daniel W Fisher; Hongxin Dong
Journal:  Neurobiol Stress       Date:  2018-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.